Table 1.

Values of IC50 of SF4.1-SF 4.5 Treatments on the Growth of WiDr Colon Cancer Cells

Mean of Viability WiDr cells line (%)*± SD
Isolate / Dosis	0.78125 µg	1.56 µg	3.125 µg	6.25 µg	12.5 µg	25 µg	50 µg	IC50**± SD(µg/ml)
SF4.1 (isolate 1)	80.55 ± 5.72	76.87 ± 5.15	65.66 ± 2.78	54.75 ± 2.03	48.3 ± 3.3	37.45 ± 1	24.1 ± 1.86	9.41 ± 1.69
SF4.2 (isolate 2)	83.55 ± 2.69	70.32 ± 0.73	61.6 ± 0.89	50.75 ± 2.36	40.3 ± 1.79	25.45 ± 3.23	14.1 ± 1.43	6.01 ± 0.74
SF4.3 (isolate 3)	86.22 ± 0.4	72.12 ± 0.99	60.2 ± 0.78	40.74 ± 0.53	37.32 ± 1.18	28.45 ± 2.3	13.3 ± 1.56	5.65 ± 0.22
SF4.4 (isolate 4)	87.43 ± 1.14	76.43 ± 0.16	56.83 ± 1.48	45.36 ± 1.06	37.65 ± 2.21	21.45 ± 3.28	1.3 ± 0.98	5.53 ± 0.53
SF4.5 (isolate 5)	76.52 ± 1.29	64.39 ± 2.06	51.23 ± 2.02	38.51 ± 0.03	28.35 ± 1.8	19.2 ± 0.76	9.32 ± 0.65	3.49 ± 0.22

^*, The average value of Viability (%) ± standard deviation with three replication;

^**, The average value of IC50 ± standard deviation with three replication